AI Summary & Key Takeaways
AI InsightIn this work a case of human immunodeficiency virus (HIV)-negative, human herpesvirus-8 (HHV-8)-positive patient with esophageal involvement of PEL who developed BEF after receiving systemic chemotherapy was presented
📌 3 Key Takeaways
Abstract
Primary effusion lymphoma (PEL) is a clinically unique entity arising predominantly as lymphomatous effusion within body cavities such as pleural, pericardial, and peritoneal spaces, typically without any accompanying extracavitary masses. Extracavitary or solid variant of PEL is a different entity which has rarely been described. Bronchoesophageal fistula (BEF) is a life-threatening complication of thoracic diseases resulting continuous pulmonary aspiration of food and saliva, which consequently leads to recurrent pulmonary infection and sepsis. In this work a case of human immunodeficiency virus (HIV)-negative, human herpesvirus-8 (HHV-8)-positive patient with esophageal involvement of PEL who developed BEF after receiving systemic chemotherapy was presented
Özet
Primer effüzyonlenfoma (PEL), plevra, perikard, periton gibi vücut boşluklarında lenfomatöz effüzyon şeklinde ortaya çıkan ve ekstrakaviter kitlelerin eşlik etmediği özel bir klinik durumdur. PEL ekstrakaviter veya solid varyantı ise daha nadir tanımlanan farklı bir klinik antitedir. Bronkoözafajiyal fistül toraks yerleşimli hastalıkların hayatı tehdit eden komplikasyonlarından biri olup, rekürren pulmoner enfeksiyon ve sepsisle sonuçlanan devamlı yemek ve tükrük aspirasyonuna neden olur. Bu çalışmada human immunodeficiency virüs (HIV)-negatif, human herpesvirüs-8 (HHV-8)-pozitif olup PEL bronkoözafajiyal tutulumu nedeni ile aldığı sistemik tedavi sonrasında bronkoözafajiyal fistül gelişen bir olgu sunulmuştur